Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response

Overview of attention for article published in The Journal of Allergy and Clinical Immunology, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy: 2 policy sources
twitter: 9 X users
patent: 1 patent

facebook: 2 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 161 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection

Cited by Centers for Disease Control and Prevention (CDC) on 16 Nov 2024

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs

Cited by American Academy of Allergy, Asthma and Immunology (AAAAI) on 01 Oct 2020

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,000 allergists / immunologists and patients' trusted resource for allergies, asthma and immune deficiency disorders.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.